Advocate Christ Medical Center in Oak Lawn, Ill., again has been recognized for excellence in the treatment of stroke patients by the American Heart Association/American Stroke Association.
The association has selected the medical center and its Neurosciences Institute for another Stroke Gold Quality Achievement Award in recognition of the institutions ongoing commitment to evidence-based stroke-care guidelines under the AHA/ASA Get With The Guidelines program.
To earn the award, the medical center stroke team had to meet specific quality achievement measures for the diagnosis and treatment of stroke patients at a set level for a designated period of time.
These measures include aggressive use of medications, such as tPA, antithrombotics, anticoagulation therapy, DVT prophylaxis, and cholesterol-reducing drugs, as well as smoking-cessation education all aimed at reducing death and disability and improving the lives of stroke patients.
In addition to the Gold Award, the medical center has made the AHA/ASAs Target: Stroke Honor Roll for following stroke quality measures that reduce the time between a patients arrival at the hospital and the onset of treatment using tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke. People who suffer a stroke and receive tPA within three hours of the start of symptoms may recover more quickly and be less likely to suffer severe disabilities, experts say.